Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Sarcoma × durvalumab × Gynecologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 6 Head & Neck 2 Dermatologic 2 Lymphoid 1 Gynecologic 1 Genitourinary 1 Gastrointestinal 1 Breast 1

Conditions

Ovarian Neoplasms 21 Uterine Cervical Neoplasms 10 Endometrial Neoplasms 10 Fallopian Tube Neoplasms 6 Carcinoma, Renal Cell 5 Breast Neoplasms 5 Triple Negative Breast Neoplasms 4 Small Cell Lung Carcinoma 4 Melanoma 4 Colorectal Neoplasms 4 Stomach Neoplasms 3 Prostatic Neoplasms 3 Head and Neck Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Vulvar Neoplasms 2 Vaginal Neoplasms 2 Uterine Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Recurrence 2 Lymphoma 2 Esophageal Neoplasms 2 Carcinoma, Transitional Cell 2 Carcinoma, Ovarian Epithelial 2 Carcinoma, Merkel Cell 2 Carcinoma, Hepatocellular 2 Urinary Bladder Neoplasms 1 Turcot syndrome 1 Sarcoma 1 Platinum-resistant Recurrent Ovarian Cancer 1 Pancreatic Neoplasms 1

Interventions

Filgrastim 12 Doxorubicin 8 Cyclophosphamide 8 Carboplatin 8 Peripheral Blood Stem Cell Transplantation 7 Ifosfamide 7 pembrolizumab 5 Radiotherapy 5 Gemcitabine 5 Etoposide 5 Cisplatin 5 Temozolomide 4 Amifostine 4 aflibercept 3 Trastuzumab 3 Specimen Handling 3 Radiosurgery 3 Paclitaxel 3 Magnetic Resonance Spectroscopy 3 Docetaxel 3 Biopsy 3 selinexor 2 pazopanib 2 palbociclib 2 eribulin 2 entrectinib 2 belinostat 2 atezolizumab 2 aldesleukin 2 Vincristine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03085225 2025-09-04

TRAMUNE

Institut Bergonié

Phase 1 Completed

40 enrolled 23 charts

GynecologicSarcoma

Ovarian Neoplasms, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡